Table 3.
Type | Subtype | Number | Male | Female | Median Age, Yrs (Range) |
---|---|---|---|---|---|
MDS/Leukemia | AML | 10 | 6 | 2 | 22 (1.2–44) |
ALL | 1 | 0 | 1 | 13 | |
MDS* | 5 | 5 | 0 | 21 (15–45) | |
Tumors | Total Tumors | 19 | 10 | 9 | 23 (4–36) |
Osteosarcoma | 6 | 2 | 4 | 12 (4–23) | |
Soft tissue sarcoma | 1 | 1 | 0 | 30 | |
Breast | 2 | 0 | 2 | 26, 27 | |
Hodgkin | 3 | 3 | 0 | 7,15,23 | |
Hepatoma | 2 | 2 | 0 | 24,26 | |
Stomach | 1 | 1 | 0 | 26 | |
Melanoma | 1 | 0 | 1 | 36 | |
Colon | 1 | 0 | 1 | 34 | |
Fibrohistiocytoma | 1 | 1 | 0 | 23 | |
Non Hodgkin Lymphoma | 1 | 0 | 1 | 15 |
Abbreviations as in (A). Thirty patients had cancer.
1 MDS evolved to AML. I MDs followed chemotherapy for Hodgkin lymphoma.